AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,673 | +18.0% | 64,529 | +21.9% | 0.00% | +33.3% |
| Q2 2023 | $665,065 | +72.4% | 52,951 | +52.3% | 0.00% | +50.0% |
| Q1 2023 | $385,688 | -67.5% | 34,778 | -68.6% | 0.00% | -71.4% |
| Q2 2022 | $1,188,000 | -52.3% | 110,652 | +2.5% | 0.01% | -53.3% |
| Q4 2020 | $2,492,000 | +1340.5% | 107,942 | +837.5% | 0.02% | +1400.0% |
| Q1 2018 | $173,000 | -92.3% | 11,514 | -92.6% | 0.00% | -92.3% |
| Q4 2017 | $2,250,000 | -65.0% | 156,326 | -63.4% | 0.01% | -66.7% |
| Q3 2017 | $6,433,000 | +2837.4% | 426,589 | +1861.3% | 0.04% | +3800.0% |
| Q2 2017 | $219,000 | -82.6% | 21,750 | -83.2% | 0.00% | -90.0% |
| Q4 2015 | $1,256,000 | -76.6% | 129,434 | -66.2% | 0.01% | -76.7% |
| Q3 2015 | $5,358,000 | -45.3% | 382,959 | -44.7% | 0.04% | -51.7% |
| Q2 2015 | $9,791,000 | +7.6% | 691,934 | -17.3% | 0.09% | +15.6% |
| Q1 2015 | $9,102,000 | +108.0% | 836,609 | +59.1% | 0.08% | +120.0% |
| Q4 2014 | $4,376,000 | +438.3% | 525,909 | +285.0% | 0.04% | +400.0% |
| Q3 2014 | $813,000 | +2363.6% | 136,600 | +834.1% | 0.01% | – |
| Q1 2014 | $33,000 | – | 14,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |